Dreavent Capital
Overview
Dreavent Capital is a Massachusetts-based venture capital firm dedicated to advancing human health by investing in early-stage U.S. biopharmaceutical companies. Their focus is on developing transformative treatments in immunology, oncology, and neurology, aiming to address critical medical needs and improve patient outcomes. The firm employs a rigorous selection process, known as 'The Dreavent Engine,' to identify high-potential biotech companies that have progressed to the Investigational New Drug (IND) phase through Phase 2 clinical trials. This approach ensures that investments are made in companies with demonstrated proof of concept and a clearer path to market. Dreavent Capital's investment strategy emphasizes strong industry partnerships, seeking companies backed by at least one large pharmaceutical company and one established venture capital firm. This collaborative approach enhances the success probability and operational efficiency of their portfolio companies. Additionally, Dreavent Capital maintains an extensive network within the biotech ecosystem, including collaborations with major pharmaceutical companies and top venture capitalists, to access high-quality investments and foster innovation. Their portfolio includes companies such as Aardvark Therapeutics, Chimeron Bio, Elicio Therapeutics, Inspirna, Nido Bio Sciences, and Therini Bio, reflecting their commitment to supporting innovative solutions in the biotech sector. Through these strategic investments and partnerships, Dreavent Capital aims to drive significant advancements in medical treatments and contribute to the overall progress of the healthcare industry.
Investment Focus
- Companies in the IND phase through Phase 2 clinical trials
- Backed by at least one large pharmaceutical company
- Supported by at least one established venture capital firm
Portfolio Companies
Get the full list of 54,000+ investors
Dreavent Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Dreavent Capital
What sectors does Dreavent Capital invest in?
Dreavent Capital invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Massachusetts, United States. Dreavent Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Dreavent Capital invest at?
Dreavent Capital backs companies at Early Stage, Series A and Series B, writing cheques of 5M - 20M.
Which regions does Dreavent Capital invest in?
Dreavent Capital invests across United States.
What companies has Dreavent Capital invested in?
Dreavent Capital's portfolio includes Aardvark Therapeutics, Therini Bio, Chimeron Bio, Elicio Therapeutics, Inspirna and Nido Bio Sciences.
Last updated · Source: ConnectSafely investor database
